Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Movetis Begins Phase 3 Trial of Prucalopride

September 29, 2010 6:49 am | News | Comments

Movetis NV announces that it has started a phase 3 clinical trial with prucalopride in male patients with chronic constipation. Positive results from this clinical trial should allow Movetis to apply for expansion of the current label of Resolor.

TOPICS:

Depomed Receives Milestone Payment from Covidien

September 29, 2010 6:44 am | News | Comments

Depomed received a $500,000 payment from its partner Covidien PLC, which has started human testing of an extended-release painkiller using its technology.

TOPICS:

XOMA Completes Enrollment of Phase 2 Diabetes Trial

September 29, 2010 6:39 am | News | Comments

XOMA Ltd. announced that patient enrollment was recently completed for the company's Phase 2a trial of XOMA 052 in patients with Type 2 diabetes. XOMA 052 is a therapeutic antibody candidate that inhibits the inflammatory cytokine interleukin-1 beta.

TOPICS:
Advertisement

Protein Expression

September 28, 2010 8:52 am | Product Releases | Comments

AMSBIO has announced Solu BL21 Competent E. coli, a significantly improved BL21 host strain for soluble mammalian protein expression.

TOPICS:

Mass Spectrometer

September 28, 2010 8:50 am | Product Releases | Comments

The AB SCIEX TripleTOF 5600 System is a fast and sensitive high-resolution mass spectrometer for high-performance qualitative and quantitative analysis.

TOPICS:

Microplate Mixer

September 28, 2010 8:46 am | Product Releases | Comments

Microsonic Systems has announced that its HENDRIX SM100 now serves four key applications: Compound solubilization, Sample thawing, Microplate mixing, and Magnetic particles/cells suspension.

TOPICS:

GATC Biotech Plans to Sequence 100k Genomes By 2015

September 28, 2010 8:30 am | News | Comments

Within the next four years GATC Biotech plans to analyse 100,000 human genomes in particular for the pharmaceutical and diagnostic industry as well as for academic research.

TOPICS:

Walgreen Income Up 8%

September 28, 2010 8:28 am | News | Comments

Walgreen Co., the largest drugstore chain in the U.S., said its net income rose 8 percent in the fiscal fourth quarter on higher prescription drug sales.

TOPICS:
Advertisement

Chelsea Therapeutics Beginning RA Drug Trial

September 28, 2010 8:22 am | News | Comments

Chelsea Therapeutics International, Ltd. has initiated enrollment in a Phase 2 trial designed to compare the efficacy and tolerability of CH-4051 against methotrexate in patients with rheumatoid arthritis who are experiencing an inadequate response to methotrexate.

TOPICS:

Cytheris Registering Patients for INSPIRE 3

September 28, 2010 8:18 am | News | Comments

Cytheris SA announced that it has begun enrolling patients in a Phase 2 clinical trial evaluating the effect of repeated cycles of CYT107 in HIV-1 infected patients classified as immunological non-responders after at least 24 months of HAART.

TOPICS:

Wider Statin Use Could Cut Costs in Long Run

September 28, 2010 7:47 am | News | Comments

A new analysis suggests that broader statin use among adult patients may be a cost-effective way to prevent heart attack and stroke.

TOPICS:

SNPs Lead to Painful Aromatase Inhibitor Side Effects

September 28, 2010 7:44 am | News | Comments

Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer.

TOPICS:

Nanoneedle Delivers Quantum Dots

September 28, 2010 7:41 am | News | Comments

Getting an inside look at the center of a cell can be as easy as a needle prick, thanks to researchers who have developed a tiny needle to deliver a shot right to a cell's nucleus.

TOPICS:

US Vulnerable to MDR-TB

September 28, 2010 7:26 am | News | Comments

While the U.S. has made great progress in the prevention and treatment of tuberculosis, the nation has become more susceptible to potential epidemics of multidrug-resistant tuberculosis.

TOPICS:

Drug Shortage Holding Up Executions

September 28, 2010 7:18 am | by Andrew Welsh-Huggins | News | Comments

Some executions in the U.S. have been put on hold because of a shortage of one of the drugs used in lethal injections from coast to coast. Several of the 35 states that rely on lethal injection are either scrambling to find sodium thiopental or considering using another drug.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading